| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/26/2011 | US7985591 Dirofilaria cuticle protein for use in identifying modulators and preparing vaccines for prevention and treatment worm infection |
| 07/26/2011 | US7985587 Methods of culturing dermal papilla cells |
| 07/26/2011 | US7985410 Method or agent for inhibiting the function of efflux pump Pseudomonas aeruginosa |
| 07/26/2011 | CA2481325C Anti-hiv composition, production method thereof and medicament |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2299677C Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011088451A1 Uses of influenza virus-like particles (vlps) for characterization of neuraminidase and hemagglutinin activity |
| 07/21/2011 | WO2011088409A1 Fusion proteins for delivery of erythropoietin to the cns |
| 07/21/2011 | WO2011088215A2 Notch1 binding agents and methods of use thereof |
| 07/21/2011 | WO2011088120A1 Antibody formulation and therapeutic regimens |
| 07/21/2011 | WO2011087986A1 Il-22-fc and hepcidin activity |
| 07/21/2011 | WO2011087839A1 Vaccine to influenza a virus |
| 07/21/2011 | WO2011087799A1 A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection |
| 07/21/2011 | WO2011087364A1 Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof |
| 07/21/2011 | WO2011087091A1 Anti-asct2 (system asc amino acid transporter type 2) antibody |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011086509A1 Methods of producing adenovirus vectors and viral preparations generated thereby |
| 07/21/2011 | WO2011086179A1 Methods for diagnosis and treatment of cutaneous t cell lymphomas |
| 07/21/2011 | WO2011086143A2 Liver targeting molecules |
| 07/21/2011 | WO2011086001A1 Antibodies for the treatment of hcv |
| 07/21/2011 | WO2011085783A1 Variants of the group-5 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
| 07/21/2011 | WO2011085782A1 Variants of the group-6 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
| 07/21/2011 | WO2011085653A1 Method and kit for identifying and treating graves' disease |
| 07/21/2011 | WO2011085574A1 Complete human anti-tnf-alpha monoclonal antibodies, and manufacturing methods and uses thereof |
| 07/21/2011 | WO2011066342A3 Simultaneous inhibition of pd-l1/pd-l2 |
| 07/21/2011 | WO2011064664A3 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 07/21/2011 | WO2011050104A3 Methods of using anti-cd3 antibodies to prevent weight gain |
| 07/21/2011 | WO2011035018A3 Suicide ready cells |
| 07/21/2011 | WO2011011384A9 Synthesis of dendrimer conjugates |
| 07/21/2011 | WO2011008956A3 Mammalian genes involved in infection |
| 07/21/2011 | WO2010135749A9 Herpes simplex virus type2: compositions and methods for eliciting an immune response |
| 07/21/2011 | WO2008097525A3 Local complement inhibition for treatment of complement-mediated disorders |
| 07/21/2011 | US20110179509 Use of Afamin for Treating Fertility Disorders |
| 07/21/2011 | US20110179502 Modulation of gm98 (mrf) in remyelination |
| 07/21/2011 | US20110178277 Stabilized single domain antibodies |
| 07/21/2011 | US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 07/21/2011 | US20110177596 Device for enhancing immunostimulatory capabilities of T-cells |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |
| 07/21/2011 | US20110177526 Janus family kinases and identification of immune modulators |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177163 Compositions and methods for treating hepatitis a |
| 07/21/2011 | US20110177159 Custom-formulated phospholipid microbubbles and methods and uses thereof |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177153 targeted nanoparticle drug for magnetic hyperthermia treatment on malignant tumors |
| 07/21/2011 | US20110177129 Methods and Compositions Using Peroxiredoxin 1 (PRX1) as an Adjuvant |
| 07/21/2011 | US20110177128 Immunotherapy compositions and methods of treatment |
| 07/21/2011 | US20110177127 Brucella Abortus Proteins and Methods of Use Thereof |
| 07/21/2011 | US20110177126 Bacteria and derived products to reinforce the body defences and to reduce the risk of disease |
| 07/21/2011 | US20110177125 Hsv-1 and hsv-2 vaccines and methods of use thereof |
| 07/21/2011 | US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/21/2011 | US20110177123 Recombinant Live Attenuated Foot-and-Mouth Disease (FMD) Vaccine Containing Mutations in the L Protein Coding Region |
| 07/21/2011 | US20110177122 Dna prime/activated vaccine boost immunization to influenza virus |
| 07/21/2011 | US20110177121 Immunogenic Influenza Composition |
| 07/21/2011 | US20110177120 Mycobacterium tuberculosis vaccine |
| 07/21/2011 | US20110177119 Stable, dried rotavirus vaccine, compositions and process for preparation thereof |
| 07/21/2011 | US20110177118 Non-Simian Cells for Growth of Porcine Reproductive and Respiratory Syndrome (PRRS) Virus |
| 07/21/2011 | US20110177117 Chimeric respiratory syncytial virus polypeptide antigens |
| 07/21/2011 | US20110177116 Methods of Immunizing Pregnant Heifers at Three Months of Gestation |
| 07/21/2011 | US20110177115 Vaccination regimen |
| 07/21/2011 | US20110177114 Immediate protection against pathogens via mva |
| 07/21/2011 | US20110177112 Multi- component l2 vaccine for prevention of human papilloma virus infection |
| 07/21/2011 | US20110177111 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 07/21/2011 | US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 07/21/2011 | US20110177109 Antigenic tau peptides and uses thereof |
| 07/21/2011 | US20110177108 Lipid compounds for supression of tumorigenesis |
| 07/21/2011 | US20110177107 Predicting and reducing alloimmunogenicity of protein therapeutics |
| 07/21/2011 | US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications |
| 07/21/2011 | US20110177104 Method for selective depletion of cd137 positive cells using anti-cd137 antibody-toxin complex |
| 07/21/2011 | US20110177103 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2011 | US20110177102 Targeted double stranded rna mediated cell killing |
| 07/21/2011 | US20110177101 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110177100 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110177099 Genetic variations associated with drug resistance |
| 07/21/2011 | US20110177098 Tm4sf4 and modulators thereof and methods for their use |
| 07/21/2011 | US20110177097 Methods for modulating expression of creb |
| 07/21/2011 | US20110177096 Use of gpr151 modulators for the treatment of pain |
| 07/21/2011 | US20110177095 Anti-her2 antibodies and their uses |
| 07/21/2011 | US20110177094 Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease |
| 07/21/2011 | US20110177093 Use of bcma as an immunoregulatory agent |
| 07/21/2011 | US20110177092 Individual 5-fluorouracile dose optimization in folfiri treatment |
| 07/21/2011 | US20110177091 Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1) |
| 07/21/2011 | US20110177090 Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies |
| 07/21/2011 | US20110177089 Apoptosis inducer |
| 07/21/2011 | US20110177088 Method for Treating and Diagnosing Hematologic Malignancies |
| 07/21/2011 | US20110177087 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 07/21/2011 | US20110177086 Methods of antagonizing signal transduction in dorsal root ganglion cells |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177084 Novel use application of sugar chain-recognizing receptor |
| 07/21/2011 | US20110177083 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177081 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 07/21/2011 | US20110177080 Novel p2x7 epitopes |
| 07/21/2011 | US20110177079 Cancer-testis antigens |
| 07/21/2011 | US20110177078 Immunogen and Antivenom Against Violin Spider Venom |